Please find enclosed the Earnings Presentation for the first quarter ended June 30, 2026

August 10, 2026 BSE Limited National Stock Exchange of India Limited The Corporate Relationship Dept. Exchange Plaza, C-1, Block- G, P.J. Towers, Dalal Street Bandra Kurla Complex, Bandra (East), Mumbai-400 001 Mumbai-400 051 Scrip Code: 500214 Symbol: IONEXCHANG Sub.: Submission of Earnings Presentation – Q1 FY 2026-27 Dear Sir/ Madam, Pursuant to Regulation 30 read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the presentation being made to the Investors and Analysts (Group Meet) to discuss the financial performance of the Company for the first quarter ended June 30, 2026. The aforesaid information is also available on the website of the Company and can be accessed at www.ionexchangeglobal.com. Kindly take the information on record. Thanking You, Yours faithfully, For Ion Exchange (India) Limited Nikisha Solanki Company Secretary & Compliance Officer ACS- 50894 Encl.: As stated above Earnings Presentation Q1-FY27 Company Snapshot 62 + OPERATIONS IN 50 + ° TOTAL WATER & YEARS OF ENVIRONMENT MANAGEMENT EXPERTISE COUNTRIES SERVING ONE OF ASIA’S LARGEST EXPORTS ACROSS INDUSTRIES, WORLD CLASS SERVICE NETWORKS CONTINENTS INSTITUTIONS, MANUFACTURING FACILITIES HOMES & COMMUNITIES GLOBAL ASSEMBLY HUBS IN ADVANCED R&D COMMITTED TO UAE, SAUDI ARABIA, SOUTH CENTRES IN INDIA SUSTAINABILITY AFRICA, INDONESIA & BANGLADESH 200,000 + 3,000 + INSTALLATIONS WORLD-WIDE CORE INDUSTRY PROJECTS Total Water & Environment Management Solutions Management of Specialty Resins / Adsorbents / Membranes / Industrial Wastewater Treatment Process Water Chemicals / Enzymes for Purification & Recycle & Zero Liquid Discharge Concentration Drinking Water Treatment Process Water Treatment – Ion Exchange Sewage Treatment, & Membrane Tertiary Sewage Recycle, Based Sludge Management Pretreatment Capabilities Leaders in Resins, Membranes & Chemicals, with a Unique End-to-End Portfolio Spanning Solutions, Digital & Services RESINS MEMBRANES CHEMICALS SOLUTIONS SERVICES DIGITAL 1 2 3 4 5 6 7 8 SOURCE WATER & PROCESS WATER HIGH PURITY WATER ULTRA PURE INDUSTRIAL WASTEWATER ZERO LIQUID DISCHARGE MUNICIPAL & SEWAGE DRINKING PRETREATMENT TREATMENT WATER TREATMENT TREATMENT WATER SOLUTIONS Global Presence COUNTRIES SERVED INTERNATIONAL REVENUE SHARE GLOBAL MANUFACTURING FACILITIES & ASSEMBLY CENTRES 200,000+ GLOBAL INSTALLATIONS Our Global Offices Global Manufacturing Facilities Ankleshwar, Gujarat Roha, Maharashtra Verna, Goa Resins Manufacturing - Exports Non-Solvent Resins Centre of Membrane Excellence Patancheru, Telangana Saudi Arabia Portugal Chemicals Manufacturing Chemical Blending Facility MAPRIL, Manufacturing Facility Global Manufacturing Facilities Hosur, Tamil Nadu Verna, Goa Wada, Maharashtra Palaspe, Maharashtra Standard Systems Assembly Standard Membrane Systems Standard Systems Assembly Large System Assembly UAE South Africa Indonesia Bangladesh Assembly Unit, ICV Certified Facility Manufacturing Facility Assembly and Testing Center Fabrication Unit & Assembly Centre Current vs New Reporting Segments Ion Exchange (India) Ltd. Current Reporting Engineering Chemicals Consumer Products New Reporting Institutional Treatment Industrial Lifecycle Specialty Consumer Solutions Products Services Chemicals Products New Reporting Segments TREATMENT INDUSTRIAL LIFECYCLE SPECIALTY CONSUMER SOLUTIONS PRODUCTS SERVICES CHEMICALS PRODUCTS 1 2 3 4 5 ▪ Water Treatment ▪ StandardWater ▪ Operations & ▪ Water Treatment ▪ Home Water Solutions Treatment Solutions Maintenance (O&M) Chemicals ▪ Ultra Pure Water ▪ CommunityWater ▪ Membranes (RO, UF, NF, ▪ Rehabilitation & ▪ Utility Chemicals Treatment Solutions ▪ High Purity Water MBR) Modification ▪ Process Chemicals ▪ Wellness ▪ Desalination ▪ Institutional Water ▪ Spares, Services & ▪ Membrane Chemicals ▪ Hydrogen Water ▪ Wastewater Treatment Treatment Products Consumables ▪ Polymers & Recycle ▪ Alkaline Water ▪ BOO/BOOT/WaaS ▪ Resins ▪ Zero Liquid Discharge ▪ Rentals ▪ Industrial (ZLD) ▪ Audits ▪ Process ▪ PFAS ▪ Pharma ▪ Remote Monitoring Financial Overview Q1-FY27 Q1-FY27 Financial Highlights Q1-FY27 Performance (Standalone) Q1-FY27 Performance (Consolidated) 4.83 % 4.54 % INR 318 Mn INR 6,356 Mn INR 307 Mn INR 7,005 Mn Operating EBITDA Operating EBITDA Operating EBITDA Operating Income Operating EBITDA Operating Income Margins Margins INR 114 Mn 1.79 % INR 0.93 /Share INR 31 Mn 0.44 % INR 0.35 /Share Net Profit PAT Margins Diluted EPS Net Profit PAT Margins Diluted EPS Order Book and Pipeline (As on 30 June, 2026) for Treatment Solutions, Industrial Products & Lifecycle Services Engineering projects^ Outstanding Sri Lanka Outstanding UP SWSM Total Orderbook Bid Pipeline ~ INR 21,820 Mn ~ INR 100 Mn ~ INR 2,810 Mn ~ INR 24,730 Mn ~ INR 97,770 Mn ^Excluding Sri Lanka Order, UP SWSM. and the recent Contract awarded to the Co –USD 52.83 Mn by Hyundai Engineering & Construction Quarterly Consolidated Segmental Breakup Treatment Solutions INR Mn 2,099 Q1-FY27 Performance Highlights 1,839 ▪ Revenue growth of 14% ▪ GCC Dispatches resumed .. To pick up momentum ▪ Margins continue to be impacted by legacy projects Future Growth Drivers 168 ▪ Existing backlog liquidation ▪ New emerging segments (174) ▪ Overseas opportunities Q1-FY26 Q1-FY27 REVENUE EBIT Quarterly Consolidated Segmental Breakup Industrial Products INR Mn 1,051 Q1-FY27 Performance Highlights ▪ Revenue growth of 14% ▪ EBIT% up from 5.53% to 11.89% ▪ Strong performance by Standard Water Treatment Solutions and Membranes 125 Future Growth Drivers ▪ Manufacturing expansion for UF Membranes ▪ Expanded capacity for Standard Plants & Systems Q1-FY26 Q1-FY27 ▪ Increasing overseas geographical reach REVENUE EBIT Quarterly Consolidated Segmental Breakup Lifecycle Services INR Mn Q1-FY27 Performance Highlights ▪ Revenue growth of 28% ▪ EBIT% down from 10.55% to 9.92% due to input costs ▪ Focus on O&M and Consumables Future Growth Drivers ▪ Expanding solution offerings ▪ Retrofit business and BOO/BOOT ▪ Digital portfolio and solutions Q1-FY26 Q1-FY27 REVENUE EBIT Quarterly Consolidated Segmental Breakup Specialty Chemicals INR Mn 2,297 1,889 Q1-FY27 Performance Highlights ▪ Revenue growth of 21% ▪ EBIT down to 9.71% due to geopolitical impact ▪ Higher costs due to Roha facility capex Future Growth Drivers ▪ Increased offtake from Roha Plant ▪ Pharma Resins Q1-FY26 Q1-FY27 ▪ Higher share in process chemicals REVENUE EBIT Quarterly Consolidated Segmental Breakup Consumer Products INR Mn 1,124 Q1-FY27 Performance Highlights ▪ Revenue Growth of 33% ▪ EBIT slightly up from -0.59% to -0.27% ▪ Strong growth across all key product lines Future Growth Drivers ▪ Growth in the Softener market ▪ Wellness product offerings (5) (3) ▪ New products like OTG Q1-FY26 Q1-FY27 REVENUE EBIT Quarterly Consolidated Financial Performance INCOME STATEMENT (INR Mn) Q1-FY27 Q1-FY26 Y-o-Y Q4-FY26 Q-o-Q Operating Income 7,005 5,832 20.1% 8,633 (18.9)% Expenses 6,687 5,205 28.5% 8,434 (20.7)% Operating EBITDA 318 627 (49.3)% 199 59.8% Operating EBITDA Margins (%) 4.54% 10.75% (622) bps 2.31% 223 bps Depreciation 218 123 77.2% 196 11.2% Finance Cost 90 26 NA 108 (16.7)% Other Income 60 177 NA 430 NA PBT before Exceptional Items 70 655 (89.3)% 325 (78.5)% Exceptional Items - - NA (1) NA PBT 70 655 (89.3)% 326 (78.5)% Share of Profit of equity accounted Investee 4 4 NA (1) NA Tax 43 175 (75.4)% 82 (47.6)% Profit After Tax 31 484 (93.6)% 243 (87.2)% PAT Margins (%) 0.44% 8.30% (786) bps 2.81% (237) Bps Other Comprehensive Income 3 21 (85.7)% 15 (80.0)% Total Comprehensive Income 34 505 (93.3)% 258 (86.8)% Diluted EPS (INR)# 0.347 4.108 (91.6)% 2.036 (83.0)% #EarningsperequityshareincludesimpactofequitysharesheldbyIEIShareholding (StaffWelfare)Trusts.&HMILShareholding (StaffWelfare) Trusts:(No.ofShares-2,37,36,140) andsharesheldbySubsidiary companies:(NoofShares:43,78,740) Quarterly Standalone Financial Performance INC [Showing first 8,000 characters — download PDF for full document]